BELITE BIO INC - ADR (BLTE) Institutional Ownership Changes & 13F Activity
BELITE BIO INC - ADR (BLTE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Maverick Capital Ltd, Logos Global Management Lp, Holocene Advisors, Lp, Citadel Advisors Llc, and Price T Rowe Associates Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -9,780 | -49.9% | 9,820 | $1.51M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +184,160 | +9171.3% | 186,168 | $28.67M | Q2 2026 | Sep 02, 2026 |
| Maverick Capital Ltd | Buy | +396,311 | — | 396,311 | $61.03M | Q2 2026 | Aug 14, 2026 |
| Logos Global Management Lp | Buy | +250,000 | — | 250,000 | $38.50M | Q2 2026 | Aug 14, 2026 |
| Holocene Advisors, Lp | Sell | -243,460 | -49.2% | 251,035 | $38.66M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -175,946 | -62.4% | 105,859 | $16.30M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +121,005 | +3202.9% | 124,783 | $19.21M | Q2 2026 | Aug 14, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +118,093 | +10.6% | 1,232,877 | $189.84M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -75,524 | -13.2% | 494,564 | $76.16M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +60,679 | +57.5% | 166,188 | $25.59M | Q2 2026 | Aug 14, 2026 |
| Fred Alger Management, Llc | Sell | -60,455 | -96.6% | 2,119 | $326.29K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +53,579 | +438.4% | 65,801 | $10.13M | Q2 2026 | Aug 14, 2026 |
| Deerfield Management Company, L.P. | Buy | +53,186 | +17.5% | 357,199 | $55.00M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +51,186 | — | 51,186 | $7.88M | Q2 2026 | Aug 14, 2026 |
| Mpm Bioimpact Llc | Buy | +49,163 | +55.8% | 137,208 | $21.13M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +38,100 | — | 38,100 | $5.87M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +34,444 | +228.5% | 49,516 | $7.62M | Q2 2026 | Aug 14, 2026 |
| Eventide Asset Management, Llc | Buy | +33,179 | +9.3% | 390,829 | $60.18M | Q2 2026 | Aug 14, 2026 |
| Pfm Health Sciences, Lp | Sell | -24,629 | -41.4% | 34,803 | $5.36M | Q2 2026 | Aug 14, 2026 |
| Darwin Global Management, Ltd. | Buy | +19,807 | +0.6% | 3,077,219 | $456.59M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +13,300 | — | 13,300 | $2.05M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +12,733 | — | 12,733 | $1.96M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +12,171 | — | 12,171 | $1.87M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -10,725 | -71.2% | 4,333 | $667.22K | Q2 2026 | Aug 14, 2026 |
| Lighthouse Investment Partners, Llc | Buy | +10,000 | — | 10,000 | $1.54M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -8,196 | -48.3% | 8,785 | $1.35M | Q2 2026 | Aug 14, 2026 |
| Balance Capital Partners L.P. | Buy | +8,000 | +55.2% | 22,500 | $3.46M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +3,029 | — | 3,029 | $466.42K | Q2 2026 | Aug 14, 2026 |
| Jain Global Llc | Buy | +2,101 | — | 2,101 | $323.52K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -1,935 | -85.7% | 322 | $50.00K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about BLTE activity
Which institutional owners are buying BLTE?
Institutional owners buying BLTE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BLTE activity?
"Buy" means an investor increased their reported position in BLTE compared to the prior reporting period. This reflects growing exposure to BELITE BIO INC - ADR (BLTE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BLTE increasing?
Institutional interest in BLTE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BLTE Institutional Insights
- BLTE Overview
- BLTE 13F Institutional Holders
- BLTE Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BLTE Insider Trading & SEC Form 4 Activity
- BLTE Articles
- Top Institutional Investor Stock Rankings